Published in J Thorac Dis on March 01, 2017
Vitamin D deficiency. N Engl J Med (2007) 59.34
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Landscape of transcription in human cells. Nature (2012) 20.18
The hallmarks of aging. Cell (2013) 14.29
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Origin and physiological roles of inflammation. Nature (2008) 11.68
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med (1987) 8.77
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Physiological migration of hematopoietic stem and progenitor cells. Science (2001) 7.02
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 6.35
Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med (2000) 5.90
MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res (2007) 5.65
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation (2003) 4.43
Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation (2006) 4.35
Inflammation as a cardiovascular risk factor. Circulation (2004) 4.26
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med (2014) 3.75
Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68
Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science (2014) 3.37
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Effects of parabiosis of obese with diabetes and normal mice. Diabetologia (1973) 3.16
Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 3.14
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res (2011) 2.99
Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell (2012) 2.91
Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci (2006) 2.85
Epidemiology of heart failure. Circ Res (2013) 2.84
Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am (2003) 2.73
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab (2015) 2.71
Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest (2009) 2.49
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol (2011) 2.40
Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation (2001) 2.29
Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol (1998) 2.26
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat Genet (2013) 2.11
Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol (2009) 1.81
Non-coding RNAs in cardiac remodeling and heart failure. Circ Res (2013) 1.66
The intersection between aging and cardiovascular disease. Circ Res (2012) 1.61
miR-34: from bench to bedside. Oncotarget (2014) 1.59
Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res (2014) 1.56
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med (2009) 1.48
Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr (2007) 1.47
Vitamin D deficiency and atrial fibrillation. Int J Cardiol (2015) 1.46
Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol (2007) 1.44
Deletion of IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice. Endocrinology (2015) 1.41
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell (2013) 1.33
Cardiovascular disease in Europe - epidemiological update 2015. Eur Heart J (2015) 1.28
Aging effects on human sympathetic neuronal function. Am J Physiol (1995) 1.25
Involvement of NADPH oxidase in age-associated cardiac remodeling. J Mol Cell Cardiol (2010) 1.25
Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension (2005) 1.25
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener (2014) 1.24
Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin (2012) 1.22
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res (2016) 1.22
An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des (2009) 1.19
GDF11 Does Not Rescue Aging-Related Pathological Hypertrophy. Circ Res (2015) 1.17
Vitamin D: a d-lightful solution for health. J Investig Med (2011) 1.15
Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. Circ Res (2015) 1.15
Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep (2005) 1.13
Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol (2005) 1.11
The aging kidney revisited: a systematic review. Ageing Res Rev (2014) 1.11
Inflammation in aging: cause, effect, or both? Discov Med (2012) 1.08
The demographic and biomedical case for late-life interventions in aging. Sci Transl Med (2010) 1.08
Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats. PLoS One (2011) 1.08
Aging populations: the health and quality of life of the elderly. Clin Ter (2011) 1.07
Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension (2002) 1.07
The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne) (2013) 1.06
Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res (2014) 1.03
Domain analysis of human transmembrane guanylyl cyclase receptors: implications for regulation. Front Biosci (2005) 1.03
Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells. Aging (Albany NY) (2014) 0.99
The role of oxidative stress and inflammation in cardiovascular aging. Biomed Res Int (2014) 0.98
A historical perspective on leptin. Nat Med (2010) 0.98
Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Circ Res (2016) 0.98
Biomarkers of Aging: From Function to Molecular Biology. Nutrients (2016) 0.95
Assessment of cardiovascular risk factors in the elderly: the Framingham Heart Study. Stat Med (1995) 0.95
This old heart: Cardiac aging and autophagy. J Mol Cell Cardiol (2014) 0.93
Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a 'passkey' to cancerogenesis. Folia Histochem Cytobiol (2012) 0.93
Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension (1995) 0.93
Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol (2015) 0.92
The Aging Heart. Cold Spring Harb Perspect Med (2015) 0.92
Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise. J Am Geriatr Soc (2012) 0.91
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail Rev (2014) 0.90
One hundred years of hormones. EMBO Rep (2005) 0.90
Modulation of glucose metabolism by the renin-angiotensin-aldosterone system. Am J Physiol Endocrinol Metab (2015) 0.89
Critical appraisal of inflammatory markers in cardiovascular risk stratification. Crit Rev Clin Lab Sci (2014) 0.89
Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer (2016) 0.88
Transient silencing of Npr3 gene expression improved the circulatory levels of atrial natriuretic peptides and attenuated β-adrenoceptor activation- induced cardiac hypertrophic growth in experimental rats. Eur J Pharmacol (2016) 0.88
The history of Osler's Principles and Practice of Medicine. Med Times (1981) 0.88
Systemic Problems: A perspective on stem cell aging and rejuvenation. Aging (Albany NY) (2015) 0.88
Immune-inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque. Curr Cardiol Rev (2016) 0.76
The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations. Expert Rev Cardiovasc Ther (2012) 0.76